Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
該当コードがありません。
から:
次の項目別のソート:
日付受信時刻ニュースソース見出しコード企業名
2024/07/3106 : 20Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:SBOWSilverBow Resources Inc
2024/07/3106 : 20Business WireSanta Clara University Announces Opus Prize Finalists
2024/07/3106 : 20PR Newswire (US)Atomic Spectroscopy Market size is set to grow by USD 2.46 billion from 2024-2028, Increased funding by government organizations for environmental testing and product safety to boost the market growth, Technavio
2024/07/3106 : 20PR Newswire (US)Drug Discovery Informatics Market size is set to grow by USD 7.28 billion from 2024-2028, Increasing R and D investments by pharmaceutical and biopharmaceutical companies boost the market, Technavio
2024/07/3106 : 19Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:SBOWSilverBow Resources Inc
2024/07/3106 : 19Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BML-LBank of America Corporation
2024/07/3106 : 19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NYSE:VLDVelo3D Inc
2024/07/3106 : 19Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:JPM-MJP Morgan Chase and Co
2024/07/3106 : 19PR Newswire (US)Ryerson Reports Second Quarter 2024 ResultsNYSE:RYIRyerson Holding Corporation
2024/07/3106 : 18Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
2024/07/3106 : 18Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BML-LBank of America Corporation
2024/07/3106 : 18Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CCitigroup Inc
2024/07/3106 : 18Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:SBOWSilverBow Resources Inc
2024/07/3106 : 18Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CCitigroup Inc
2024/07/3106 : 18Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:SBOWSilverBow Resources Inc
2024/07/3106 : 18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NYSE:HWMHowmet Aerospace Inc
2024/07/3106 : 18Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:BML-LBank of America Corporation
2024/07/3106 : 18Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
2024/07/3106 : 18Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:TELTE Connectivity Ltd
2024/07/3106 : 18Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
2024/07/3106 : 17Edgar (US Regulatory)Form 424B2 - Prospectus [Rule 424(b)(2)]NYSE:GS-JGoldman Sachs Group Inc
2024/07/3106 : 17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:SBOWSilverBow Resources Inc
2024/07/3106 : 17Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNYSE:SBOWSilverBow Resources Inc
2024/07/3106 : 17Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNASDAQ:GLPIGaming and Leisure Properties Inc
2024/07/3106 : 17GlobeNewswire Inc.Poste Italiane net profit exceeds €1 bln in first half of 2024; CEO: successful business model
2024/07/3106 : 17Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNYSE:PFEPfizer Inc
2024/07/3106 : 17Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesNYSE:CCitigroup Inc
2024/07/3106 : 17Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/07/3106 : 17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]AMEX:NGDNew Gold Inc
2024/07/3106 : 17PR Newswire (US)Gel Documentation Systems Market size is set to grow by USD 52.21 million from 2023-2027, Increase in use of molecular biology techniques in clinical practice boost the market, Technavio

最近閲覧した銘柄

Delayed Upgrade Clock